PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
56.71
ESG score 90-95% of ADAP's 62.74. Bill Ackman would demand clear ESG improvement catalysts.
54.44
Environmental score 1.1-1.2x ADAP's 50.00. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
58.35
Social score below 80% of ADAP's 78.41. Jim Chanos would check for potential social license and litigation risks.
57.34
Similar governance score to ADAP's 59.80. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.
